320 related articles for article (PubMed ID: 35165804)
21. Improved Performance of the QuantiFERON-SARS-CoV-2 Assay with the Extended Set.
Lamara Mahammed L; Bensaid K; Ait-Seddik S; Larinouna A; Brahimi G; Belkaid R; Hamzaoui O; Rouaki SM; Idder C; Allam I; Djidjik R
Viruses; 2023 May; 15(5):. PubMed ID: 37243265
[TBL] [Abstract][Full Text] [Related]
22. Comparison between enzyme-linked immunospot assay and intracellular cytokine flow cytometry assays for the evaluation of T cell response to SARS-CoV-2 after symptomatic COVID-19.
Villemonteix J; Cohen L; Guihot A; Guérin V; Moulin C; Caseris M; Carol A; Bonacorsi S; Carcelain G
Immun Inflamm Dis; 2022 Oct; 10(10):e617. PubMed ID: 36169252
[TBL] [Abstract][Full Text] [Related]
23. Assessing SARS-CoV-2-specific T-cell reactivity in late convalescents and vaccinees: Comparison and combination of QuantiFERON and activation-induced marker assays, and relation with antibody status.
Gatti A; Zizzo G; De Paschale M; Tamburello A; Castelnovo L; Faggioli PM; Clerici P; Brando B; Mazzone A
PLoS One; 2023; 18(5):e0285728. PubMed ID: 37220145
[TBL] [Abstract][Full Text] [Related]
24. Characterization of post-vaccination SARS-CoV-2 T cell subtypes in patients with different hematologic malignancies and treatments.
Pfannes R; Pierzchalski A; Maddalon A; Simion A; Zouboulis CC; Behre G; Zenclussen AC; Westphal S; Fest S; Herberth G
Front Immunol; 2023; 14():1087996. PubMed ID: 37187728
[TBL] [Abstract][Full Text] [Related]
25. High Frequencies of Functional Virus-Specific CD4
Mele D; Calastri A; Maiorano E; Cerino A; Sachs M; Oliviero B; Mantovani S; Baldanti F; Bruno R; Benazzo M; Grifoni A; Sette A; Mondelli MU; Varchetta S
Front Immunol; 2021; 12():748881. PubMed ID: 34858405
[TBL] [Abstract][Full Text] [Related]
26. Six-month immune responses to mRNA-1273 vaccine in combination antiretroviral therapy treated late presenter people with HIV according to previous SARS-CoV-2 infection.
Augello M; Bono V; Rovito R; Tincati C; d'Arminio Monforte A; Marchetti G
AIDS; 2023 Aug; 37(10):1503-1517. PubMed ID: 37199415
[TBL] [Abstract][Full Text] [Related]
27. Interferon-gamma release assays outcomes in healthy subjects following BNT162b2 mRNA COVID-19 vaccination.
Kurteva E; Vasilev G; Tumangelova-Yuzeir K; Ivanova I; Ivanova-Todorova E; Velikova T; Kyurkchiev D
Rheumatol Int; 2022 Mar; 42(3):449-456. PubMed ID: 35059799
[TBL] [Abstract][Full Text] [Related]
28. Spike protein is a key target for stronger and more persistent T-cell responses-a study of mild and asymptomatic SARS-CoV-2 infection.
Ssali I; Mugaba S; Watelo AK; Bemanzi J; Katende JS; Oluka GK; Ankunda V; Baine C; Kato L; ; Onyachi N; Muwanga M; Jjuuko M; Kayiwa J; Nsereko C; Auma BO; Weiskopf D; Sette A; Lutalo T; Musenero M; Kaleebu P; Serwanga J
Int J Infect Dis; 2023 Nov; 136():49-56. PubMed ID: 37683720
[TBL] [Abstract][Full Text] [Related]
29. B and T cell response to SARS-CoV-2 vaccination in health care professionals with and without previous COVID-19.
Zollner A; Watschinger C; Rössler A; Farcet MR; Penner A; Böhm V; Kiechl SJ; Stampfel G; Hintenberger R; Tilg H; Koch R; Antlanger M; Kreil TR; Kimpel J; Moschen AR
EBioMedicine; 2021 Aug; 70():103539. PubMed ID: 34391087
[TBL] [Abstract][Full Text] [Related]
30. A single dose of self-transcribing and replicating RNA-based SARS-CoV-2 vaccine produces protective adaptive immunity in mice.
de Alwis R; Gan ES; Chen S; Leong YS; Tan HC; Zhang SL; Yau C; Low JGH; Kalimuddin S; Matsuda D; Allen EC; Hartman P; Park KJ; Alayyoubi M; Bhaskaran H; Dukanovic A; Bao Y; Clemente B; Vega J; Roberts S; Gonzalez JA; Sablad M; Yelin R; Taylor W; Tachikawa K; Parker S; Karmali P; Davis J; Sullivan BM; Sullivan SM; Hughes SG; Chivukula P; Ooi EE
Mol Ther; 2021 Jun; 29(6):1970-1983. PubMed ID: 33823303
[TBL] [Abstract][Full Text] [Related]
31. Rapid Quantitative Point-Of-Care Diagnostic Test for Post COVID-19 Vaccination Antibody Monitoring.
Moeller ME; Engsig FN; Bade M; Fock J; Pah P; Soerensen AL; Bang D; Donolato M; Benfield T
Microbiol Spectr; 2022 Apr; 10(2):e0039622. PubMed ID: 35357223
[TBL] [Abstract][Full Text] [Related]
32. T Cell Responses in Pregnant Women Who Received mRNA-Based Vaccination to Prevent COVID-19 Revealed Unknown Exposure to the Natural Infection and Numerous SARS-CoV-2-Specific CD4- CD8- Double Negative T Cells and Regulatory T Cells.
Chambers CD; Song J; da Silva Antunes R; Sette A; Franco A
Int J Mol Sci; 2024 Feb; 25(4):. PubMed ID: 38396707
[TBL] [Abstract][Full Text] [Related]
33. Evaluation of QuantiFERON SARS-CoV-2 interferon-γ release assay following SARS-CoV-2 infection and vaccination.
Johnson SA; Phillips E; Adele S; Longet S; Malone T; Mason C; Stafford L; Jamsen A; Gardiner S; Deeks A; Neo J; Blurton EJ; White J; Ali M; Kronsteiner B; Wilson JD; Skelly DT; Jeffery K; Conlon CP; Goulder P; Consortium P; Carroll M; Barnes E; Klenerman P; Dunachie SJ
Clin Exp Immunol; 2023 Jun; 212(3):249-261. PubMed ID: 36807499
[TBL] [Abstract][Full Text] [Related]
34. Performance of the QuantiFERON-cytomegalovirus (CMV) assay for detection and estimation of the magnitude and functionality of the CMV-specific gamma interferon-producing CD8(+) T-cell response in allogeneic stem cell transplant recipients.
Clari MÁ; Muñoz-Cobo B; Solano C; Benet I; Costa E; Remigia MJ; Bravo D; Amat P; Navarro D
Clin Vaccine Immunol; 2012 May; 19(5):791-6. PubMed ID: 22379065
[TBL] [Abstract][Full Text] [Related]
35. A snapshot of the immunogenicity, efficacy and safety of a full course of BNT162b2 anti-SARS-CoV-2 vaccine in cancer patients treated with PD-1/PD-L1 inhibitors: a longitudinal cohort study.
Lasagna A; Agustoni F; Percivalle E; Borgetto S; Paulet A; Comolli G; Sarasini A; Bergami F; Sammartino JC; Ferrari A; Zavaglio F; Arena F; Lilleri D; Secondino S; Falzoni M; Schiavo R; Klersy C; Lo Cascio G; Cavanna L; Baldanti F; Pedrazzoli P; Cassaniti I
ESMO Open; 2021 Oct; 6(5):100272. PubMed ID: 34543863
[TBL] [Abstract][Full Text] [Related]
36. A Highly Specific Assay for the Detection of SARS-CoV-2-Reactive CD4
Zelba H; Worbs D; Harter J; Pieper N; Kyzirakos-Feger C; Kayser S; Seibold M; Bartsch O; Ködding J; Biskup S
J Immunol; 2021 Feb; 206(3):580-587. PubMed ID: 33298615
[TBL] [Abstract][Full Text] [Related]
37. A performance comparison of two (electro) chemiluminescence immunoassays for detection and quantitation of serum anti-spike antibodies according to SARS-CoV-2 vaccination and infections status.
Camacho J; Albert E; Zulaica J; Álvarez-Rodríguez B; Rusu L; Olea B; Alcaraz MJ; Geller R; Giménez E; Navarro D
J Med Virol; 2023 Jan; 95(1):e28397. PubMed ID: 36504019
[TBL] [Abstract][Full Text] [Related]
38. Successive Site Translocating Inoculation Improved T Cell Responses Elicited by a DNA Vaccine Encoding SARS-CoV-2 S Protein.
Tian X; Zhang Y; He Z; Li S; Yan D; Zhu Z; Wan Y; Wang W
Front Immunol; 2022; 13():875236. PubMed ID: 35514964
[TBL] [Abstract][Full Text] [Related]
39. SARS-CoV2 wild type and mutant specific humoral and T cell immunity is superior after vaccination than after natural infection.
Richardson JR; Götz R; Mayr V; Lohse MJ; Holthoff HP; Ungerer M
PLoS One; 2022; 17(4):e0266701. PubMed ID: 35468147
[TBL] [Abstract][Full Text] [Related]
40. SARS-CoV-2 vaccination diversifies the CD4+ spike-reactive T cell repertoire in patients with prior SARS-CoV-2 infection.
Dykema AG; Zhang B; Woldemeskel BA; Garliss CC; Rashid R; Westlake T; Zhang L; Zhang J; Cheung LS; Caushi JX; Pardoll DM; Cox AL; Ji H; Smith KN; Blankson JN
EBioMedicine; 2022 Jun; 80():104048. PubMed ID: 35533495
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
